Hepatorenal syndrome in cirrhotic patients: terlipressine is a safe and efficient treatment; propranolol and digitalic treatments: precipitating and preventing factors?

Am J Gastroenterol. 2000 Oct;95(10):2984-5. doi: 10.1111/j.1572-0241.2000.03214.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Digitoxin / adverse effects*
  • Digitoxin / therapeutic use
  • Female
  • Hepatorenal Syndrome / chemically induced
  • Hepatorenal Syndrome / drug therapy*
  • Humans
  • Kidney Function Tests
  • Liver Cirrhosis, Alcoholic / drug therapy*
  • Lypressin / adverse effects
  • Lypressin / analogs & derivatives*
  • Lypressin / therapeutic use
  • Male
  • Middle Aged
  • Propranolol / adverse effects*
  • Propranolol / therapeutic use
  • Recurrence
  • Terlipressin
  • Vasoconstrictor Agents / adverse effects
  • Vasoconstrictor Agents / therapeutic use*

Substances

  • Vasoconstrictor Agents
  • Lypressin
  • Terlipressin
  • Propranolol
  • Digitoxin